- •Foreword
- •Preface
- •Contents
- •Contributors
- •Chapter 1
- •1.1 Introduction
- •1.2 Limitations of Time-Domain OCT
- •1.4 Conclusion
- •References
- •Chapter 2
- •2.1 Background
- •2.3 Clinical Application
- •2.4 Conclusions
- •References
- •Chapter 3
- •Fluorescein Angiography
- •3.1 Principles of Fluorescein Angiography
- •3.2 Procedures for Fluorescein Angiography
- •3.4 Time Course of Fluorescein Angiography
- •3.5 Interpretation of Fluorescein Angiography
- •3.5.1 Hypofluorescent Lesions
- •3.5.2 Hyperfluorescent Lesions
- •3.6 Fluorescein Angiography Today
- •References
- •Chapter 4
- •Wide-Field Imaging and Angiography
- •4.1 Introduction
- •4.2 History of Fundus Imaging
- •4.3.1 Fluorescein Angiography with a Scanning Laser Ophthalmoscope
- •4.3.2 Advantages of Imaging with a Scanning Laser Ophthalmoscope
- •4.4 Clinical Use of Wide-Field Imaging
- •4.4.1 Wide-Field Imaging in Uveitis
- •4.4.4 Wide-Field Imaging of Choroidal Tumors
- •4.5 Future Directions for Fundus Imaging
- •4.6 Conclusion
- •References
- •Chapter 5
- •Autofluorescence Imaging
- •5.1 Introduction
- •5.2 What is Fundus Autofluorescence?
- •5.3 Identification of Early Disease Stages
- •5.4 Phenotyping
- •5.5 Disease Markers
- •5.6 Monitoring of Disease Progression
- •5.7 Disease Mapping
- •5.8 Functional Correlation
- •References
- •Chapter 6
- •Imaging the Macular Pigment
- •6.1 Macular Pigment
- •6.1.1 Characteristics and Potential Functions
- •6.1.3 Spatial Distribution
- •6.1.4 Modifying the Macular Pigment
- •6.1.5 MPOD and Age
- •6.2 Measurement Techniques
- •6.2.1 Heterochromatic Flickerphotometry
- •6.2.2 Fundus reflectance
- •6.2.3 Autofluorescence
- •6.2.4 Raman spectroscopy
- •6.2.5 How do different techniques compare
- •6.3 Imaging
- •6.3.1 Heterochromatic Flickerphotometry
- •6.3.2 Fundus Reflectance
- •6.3.3 Autofluorescence
- •6.3.4 Raman spectroscopy
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Origin of Near-Infrared Autofluorescence
- •7.3 RPE Melanin: Role and Aging
- •7.4 Clinical Cases
- •7.4.1 Age-Related Macular Degeneration
- •7.4.2 Retinal Dystrophies
- •7.4.2.1 Stargardt’s Disease
- •7.4.2.2 Best’s Disease
- •7.4.2.3 Retinitis Pigmentosa
- •7.5 Conclusion
- •References
- •Chapter 8
- •8.1 Introduction
- •8.3.1.1 Classic Choroidal Neovascularization
- •8.3.1.2 Occult Choroidal Neovascularization
- •8.3.1.4 Mixed-Type Choroidal Neovascularization
- •8.3.1.5 Retinal Angiomatous Proliferation
- •8.3.3 Fibrovascular Scar
- •8.5 Conclusions
- •References
- •Chapter 9
- •9.1 Fundus Cameras
- •9.1.1 Standard Images
- •9.1.2 Wide-Angle Images
- •9.1.2.1 Pomerantzeff Equator Plus
- •9.1.2.2 RetCam™
- •RetCam™ Camera Description
- •RetCam™ Technique of Image Capture
- •RetCam™ Problems
- •9.1.2.3 Panoret™
- •9.1.2.4 Optos™
- •9.2.1 Retinal Tumors
- •9.2.1.1 Retinoblastoma
- •9.2.1.2 Astrocytic Hamartoma
- •9.2.1.4 Retinal Cavernous Hemangioma
- •9.2.1.5 Retinal Racemose Hemangioma
- •9.2.1.6 Vasoproliferative Tumor
- •9.2.2 Retinal Pigment Epithelium Tumors
- •9.2.3 Choroidal Tumors
- •9.2.3.1 Choroidal Nevus
- •9.2.3.2 Choroidal Melanoma
- •9.2.4 Anterior Segment Lesions
- •9.2.4.1 Iris Lesions
- •References
- •Chapter 10
- •Metabolic Mapping
- •10.1 Aspects of Metabolism
- •10.4.1 Technical Solution
- •10.5 Clinical Results
- •10.5.1 Age-Related Macular Degeneration
- •10.5.1.1 Detection of Alterations in Early AMD
- •10.5.1.2 Lifetime Images in Late AMD
- •Non-Exudative AMD and Geographic Atrophy
- •Exudative AMD
- •10.5.2.1 Arterial Branch Occlusion
- •10.5.3 Metabolic Alteration in Diabetes Mellitus
- •10.5.3.1 Detection of Fields of Reduced Metabolism
- •References
- •Chapter 11
- •11.1 Diabetic Macular Edema
- •11.2 Examinations in Diabetic Macular Edema
- •11.3 Treatment of Diabetic Macular Edema
- •References
- •Chapter 12
- •12.1.1 Incidence and Natural History
- •12.2 Investigation of Diagnostic Accuracy of OCT for Detection of DME
- •12.2.2 Diagnostic Accuracy of OCT for Detection of DME: Are Photography or Biomicroscopy a Valid Gold Standard?
- •12.2.3 Diagnostic Accuracy of OCT to Detect CSME Using Time-Domain OCTs: How to Use OCT Retinal Thickness Cut-Offs?
- •12.3 Use of OCT When Compared with Photography: Beyond Diagnostic Accuracy
- •12.4 Appendix: Reproducibility of OCT Retinal-Thickness Measurement in Patients with DME
- •12.4.1 How Reproducibility is Reported
- •12.4.3 Spectral-Domain OCTs Reproducibility
- •References
- •Chapter 13
- •13.2 Clinical Features
- •13.3 Examination
- •13.4 Natural History
- •13.5 Ultra-High Resolution OCT and Spectral OCT Findings in Macular Holes
- •13.6 Macular Hole Formation
- •13.7 Postoperative Appearance
- •13.8 Theory of Macular Hole Closure After Vitrectomy
- •13.9 Surgical Considerations
- •13.11 Clinical Features
- •13.12 Treatment
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Vitreous Biochemistry
- •14.3 Vitreo-Retinal Interface Anatomy
- •14.4 Anomalous Posterior Vitreous Detachment (PVD)
- •14.5 Spectral-Domain OCT (SD-OCT)
- •14.6 Vitreo-Maculopathies
- •14.6.1 Macular Pucker (MP)
- •14.6.2 Macular Hole (MH)
- •14.6.2.1 Lamellar Hole (LH)
- •14.6.3 Age-Related Macular Degeneration (AMD)
- •14.6.4 Vitreo-Macular Traction Syndrome (VMTS)
- •14.7 Conclusion
- •References
- •Chapter 15
- •15.3 Imaging the Choroid
- •15.4 Age-Related Choroidal Atrophy
- •15.5 Choroid in High Myopia
- •15.8 Volume Rendering
- •15.9 Summary
- •References
- •Chapter 16
- •16.1 Introduction
- •16.2 Optical Coherence Tomography
- •16.3 Role of Optical Coherence Tomography
- •References
- •Chapter 17
- •17.1 Background and Motivation
- •17.2 Three-Dimensional Imaging of the Choroid
- •17.3 In Vivo Cellular Resolution Retinal Imaging
- •17.4 Polarization Sensitive Retinal OCT
- •17.5 Doppler (Blood Flow) Retinal OCT
- •References
- •Chapter 18
- •Toward Molecular Imaging
- •Summaries for the Clinician
- •References
- •Index
162 |
14 Combined Spectral-Domain Optical Coherence Tomography |
|
the reticulo-endothelial system, hyalocytes act as “sentinel |
|
cells” and are responsible for antigen processing as well as |
|
eliciting monocyte migration from the circulatory system. |
14 |
Glial and RPE cells are exposed to the cytokines and growth |
factors elaborated by hyalocytes and also participate (per- |
haps as innocent bystanders) in the process of proliferative vitreo-retinal membrane formation [24]. This most likely accounts for the hypercellularity of premacular membranes in MP. Hyalocytes have also been shown to be capable of inducing membrane contraction [25], another important component in the pathophysiology of MP. Thus, following anomalous PVD with vitreoschisis, the remnant hyalocytes can induce cell migration and proliferation as well as collagen contraction, all important features of macular MP.
Recent studies using OCT/SLO detected multifocal retinal contraction in nearly half of eyes with MP (Fig. 14.6) [20]. In this investigation, multifocal retinal contraction was associated with more intraretinal cysts and macular edema than unifocal MP, suggesting that multifocality may cause greater retinal damage, possibly due to greater amounts of tangential traction. Another feature that has been found to be associated with the formation of intraretinal cysts in MP is VPA (Fig. 14.7). In that study [17], a higher incidence of intraretinal cysts was found in eyes with MP and VPA (80%) when compared with those having MP without VPA (4.3%), suggesting that VPA may
Fig. 14.6 Multifocal retinal contraction in MP. The coronal plane OCT image shows three centers of retinal contraction. Studies have shown that nearly half of eyes with MP have multifocality on coronal plane imaging. The number of contraction centers also appears to correlate with the degree of retinal damage, possibly secondary to greater tractional force
contribute to intraretinal cyst formation by providing an anchor for the forces of tangential traction on the macula.
14.6.2 Macular Hole (MH)
Macular hole (MH) is characterized by a full-thickness defect of the neural retina in the center of the macula. Most cases are unilateral, but 10–20% of patients can be affected bilaterally. Presenting symptoms include central visual distortion, central scotomas, and loss of visual acuity. The prevalence of MH has been reported to be 1:3,300, usually affecting patients in the 6th and 7th decades of life [26]. The incidence in women is twice as high as in men [27]. SD-OCT/SLO is particularly helpful in identifying and staging MH as it provides precise in vivo measurement of MH diameter as well as accurate characterization of the vitreo-macular interface.
The cause of MH is not known. Gass described four stages based on biomicroscopic observations [28–30]. In a stage 1 MH, the retina is believed to be intact without neural retinal defect or vitreo-foveal separation. Oblique vitreous traction on the fovea has been speculated to be the initial mechanism. Stage 1 MH can be further divided into stage 1a and stage 1b, the former characterized by a small central yellow spot representing cystic changes within the fovea [31]. Tangential vitreous traction on the fovea may cause elevation of the fovea, foveal detachment, and an increase in the xanthophyllic pigment. A yellow ring in the foveal area with a bridging interface characterizes stage 1b MH. An MH progresses to stage 2 when the vitreofoveal separation occurs. Recently, it has been proposed that perifoveal vitreous detachment is the primary pathogenic event in MH formation [32]. A stage 2 MH is characterized by a central or eccentric full thickness retinal defect (100–300 mm) with or without an overlying pseudo-operculum. Unlike stage 1 MH, most stage 2 holes will advance to stage 3 as a result of persistent vitreo-foveal traction. Stage 3 MH is characterized by a central round full-thickness retinal defect (350–600 mm) associated with a gray ring surrounding the hole (previously believed to be a cuff of subretinal fluid), yellow deposits, and cystic changes. A stage 4 MH is distinguished from a stage 3 MH by a complete PVD.
Recent studies have identified vitreoschisis (Fig. 14.8) in 53% of eyes with MH. The vectors of force that induce tangential vitreo-retinal traction most likely result from anomalous PVD, but there may also be a contribution from persistent adhesion of vitreous to the optic disc. Studies [17] have shown that VPA is far more prevalent in MH (87.5%) than lamellar hole (LH) (36.4%) and MP (17.9%), suggesting that persistent adhesion at the disc
14.6 Vitreo-Maculopathies |
163 |
Fig. 14.7 VPA in MP. The presence of VPA in MP has been associated with a higher incidence of intraretinal cysts, most likely due to tangential traction exerted by the persistent adhesion of vitreous to the optic disc. The longitudinal OCT/SLO image demonstrates persistent vitreous attachment at the margin of the optic disc
Fig. 14.8 Vitreoschisis in MH. Studies have shown that about half of patients with MH have vitreoschisis. In this OCT/SLO scan of an eye with a stage 3 MH, the inner wall is anterior and the outer wall is posterior, attached to the inner surface of the retina (arrow)
may contribute to the hole formation. While anomalous PVD with vitreoschisis may be the initial event in the pathophysiology of both MH and MP, VPA could influence the vector of forces and subsequent course of pathology. Persistent traction at the disc provides an anchor for outward (centrifugal) tangential traction, resulting in central retinal dehiscence and MH development (Fig. 14.9). In the absence of VPA, inward (centripetal) tangential traction is more likely and will result in MP.
In recent years, vitrectomy with membrane peel and air-fluid exchange has become a successful treatment for MH, with a very high (85–100%) reported closure rate [33, 34]. Intraoperative findings and histological analyses have determined that these membranes are thin and hypocellular. This is consistent with the hypothesis that if
anomalous PVD and vitreoschisis play a role in MH pathogenesis, then the split most likely occurs posterior to the level of the hyalocytes embedded in the posterior vitreous cortex [11]. These cells separate away from the retina along with the anterior portion of the posterior vitreous cortex, leaving the thinner, hypocellular portion attached to the macula. Persistent attachment of vitreous to the optic disc (found in 87.5% of cases) somehow influences the tangential forces that open a dehiscence in the central macula (Fig. 14.9).
Another interesting feature that was demonstrated by coronal plane imaging with combined OCT/SLO was that 40% of subjects with MH also have eccentric MP. Thus, the level of the split, which occurs during anomalous PVD with vitreoschisis, may not be the same in all MP
